Study of dose-dependent combination immunotherapy using engineered T cells and IL-2 in cervical cancer

Publication date: Available online 18 July 2020Source: Journal of Theoretical BiologyAuthor(s): Heyrim Cho, Zuping Wang, Doron Levy

Source: Journal of Theoretical Biology - July 20, 2020 Category: Biology Source Type: research